Clin2
NCT07879430Possibly a fitNot yet recruiting

Comparing 1-month versus 6-month blood thinners after balloon treatment

Coronary Artery Disease (CAD)

Part of Heart & circulation clinical trials.

This trial compares taking a single blood thinner (aspirin) for 1 month versus 6 months after a special balloon treatment (called a drug-coated balloon, or DCB) to open a blocked heart artery. The goal is to see if the shorter course is just as safe and effective, meaning some people might avoid the risks of longer blood-thinner use.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,258 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years or older.
  • You had a drug-coated balloon (DCB) treatment to open a blocked heart artery, without any stent being placed.
  • You are medically stable after the procedure (no severe complications, good blood flow).
  • You do not need blood thinners for other reasons (like a heart rhythm problem) and are not on them.
  • You do not have a history of stent-related problems or prior bypass surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07374718Not yet recruiting
Shorter blood thinner treatment after heart stent for high bleeding risk

This study tests a shorter, gentler blood thinner plan after getting a heart stent. It is designed for people who have had a heart attack or unstable angina and who are at higher risk of bleeding, to help prevent future heart problems with less bleeding risk.

Shenyang, Liaoning
NCT07363161Recruiting
Drug-coated balloon vs. stent for high-risk heart disease

This trial compares two treatments for people with complex coronary artery disease who have high-risk conditions or complicated blockages: a drug-coated balloon (DCB) versus a drug-eluting stent (DES). Both are ways to open up narrowed arteries and keep them open without surgery.

Homburg
NCT07815106Not yet recruiting· Phase 4
Shorter dual antiplatelet therapy after drug-coated balloon for coronary disease

This study tests whether a shorter period of dual blood-thinning therapy (two medicines) is as safe and effective as the standard longer period after a drug-coated balloon procedure for blocked heart arteries. You may join if you've already had the procedure and have been stable for a month.

NCT07592507Not yet recruiting· Phase 4
Blood thinner duration after balloon angioplasty for small heart arteries

This study compares taking blood-thinning medicine for 1 month versus 6 months after a balloon angioplasty to open a small heart artery. The goal is to find out which duration is safer and more effective for preventing future heart problems.

NCT07587099Recruiting
Single vs. Dual Blood Thinners After Balloon Heart Treatment

This study compares whether patients who receive a special drug-coated balloon to open a blocked heart artery (without a stent) need to take one or two blood-thinning medications afterward. The goal is to find the safest and most effective approach for preventing future blockages.

Beijing, Beijing Municipality
NCT06535568Recruiting
Comparing one vs two blood thinners after heart artery balloon treatment

This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.

Milan, MI

Hear when a new Coronary Artery Disease (CAD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.